Correlation of Ultrasound and MRI Measurements of Quadratus Femoris Thickness and Ischiofemoral Distance in Clinically and Radiologically Diagnosed Ischiofemoral Impingement
MRI USG
Evaluation of the Correlation of Ultrasound Measurements of Quadratus Femoris Muscle Thickness and Ischiofemoral Distance With MR Measurements in Patients Diagnosed With Ischiofemoral Impingement by MR Imaging and Clinical Examination.
1 other identifier
observational
30
1 country
1
Brief Summary
The goal of this observational study is to evaluate the correlation between ultrasound measurements of quadratus femoris muscle thickness and ischiofemoral distance, as well as clinical parameters, with MRI measurements in patients diagnosed with ischiofemoral impingement (IFI) through MRI imaging and clinical examination. The main questions it aims to answer are: Is there a correlation between ultrasound and MRI measurements of quadratus femoris muscle thickness and ischiofemoral distance in patients with clinically and radiologically confirmed IFI? How do clinical parameters relate to ultrasound and MRI findings in these patients? What is the intra- and inter-rater reliability of ultrasound measurements for these parameters? Participants will undergo ultrasound measurement of quadratus femoris muscle thickness and ischiofemoral distance, assessment of clinical parameters related to ischiofemoral impingement, and measurements performed twice by two independent raters to assess intra- and inter-rater reliability. Researchers will compare ultrasound and MRI measurements as well as clinical parameters to determine if ultrasound can serve as a reliable and cost-effective alternative for diagnosing ischiofemoral impingement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2025
CompletedFirst Submitted
Initial submission to the registry
September 21, 2025
CompletedFirst Posted
Study publicly available on registry
September 30, 2025
CompletedSeptember 30, 2025
August 1, 2024
5 months
September 21, 2025
September 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation of ultrasonographic ischiofemoral space (IFS) and quadratus femoris muscle thickness with clinical and MRI parameters
The primary outcome is to determine the relationship between ultrasonographically measured ischiofemoral space (IFS) and quadratus femoris muscle thickness with magnetic resonance imaging (MRI) findings (IFS and quadratus femoris space) and clinical parameters including pain intensity (Visual Analog Scale, VAS) and hip function (Harris Hip Score).
Baseline (at enrollment)
Eligibility Criteria
1. Patients older than 18 years and younger than 65 years. 2. Patients diagnosed by MRI 3. Those with a body mass index below 25 kg/m2 4. those with hip pain or positive physical examination tests
You may qualify if:
- Patients older than 18 years and younger than 65 years.
- Patients diagnosed by MRI
- Those with a body mass index below 25 kg/m2
- those with hip pain or positive physical examination tests
You may not qualify if:
- Sciatic nerve damage detected on EMG
- Patients with operative ischiofemoral decompression
- Corticosteroid or any injection to the hip in the last 3 months
- History of peripheral nerve damage
- Femoroacetabular impingement
- Pregnancy
- Malignancy
- Inflammatory pathologies: rheumatic, septic
- Coxarthrosis-Kelgren-Lawrence grade 3-4
- Those who have undergone hip arthroplasty/surgery
- Causes of lumbar radiculopathy, spondylolisthesis
- Patients with increased femoral anteversion - patients with increased hip internal rotation (Toe-in)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seyrantepe Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
Istanbul, sarıyer, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Jülide Öncü Alptekin, Professor
Sisli Hamidiye Etfal Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 8 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Resident Physician, Department of Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
September 21, 2025
First Posted
September 30, 2025
Study Start
October 10, 2024
Primary Completion
March 10, 2025
Study Completion
April 10, 2025
Last Updated
September 30, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share